scorecardresearchGlaxosmithkline Pharmaceuticals Share Price Live NSE, BSE, Today - Glaxosmithkline

Glaxosmithkline Pharmaceuticals

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | SECTOR: Biotechnology & Drugs

2,358.10 66.55 (2.9%)

18 May 2024, 06:59 (IST)
  • Open

    2,376.50
  • High

    2,392.20
  • Low

    2,340.00
  • Prev Close

    2,291.55
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    399.49B
  • Volume

    2.67K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    2,358.10
  • Ask

    2,370.00

Company Description

  • Biotechnology & Drugs
  • BSE

    500660
  • NSE

    GLAXO
  • ISIN

    INE159A01016

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.

Company Officers

  • Juby Chandy

    Chief Financial Officer, Whole Time Director
  • Chinmay Sharma

    Executive Vice President of Human Resources
  • S. Choudhary

    Executive Vice President - Regulatory Affairs
  • Ransom D'Souza

    Executive Vice President - Communications and Government Affairs
  • Rashmi Hegde

    Executive Vice President - Medical Affairs
  • Shourov Mukherjee

    Executive Vice President - Adult Vaccines
  • Amit Pandey

    Executive Vice President - Legal
  • Upendra Singh

    Executive Vice President - General Medicines
  • Ritesh Manchanda

    Vice President - Customer Supply Chain
  • Sougato Mitra

    Vice President - Specialty